📰 High Affinity Ligands News
High Affinity Ligands News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from High Affinity Ligands. Real-time updates on events, politics, business and more.
April 10, 2023
Aviceda Therapeutics, a clinical-stage biotech company focused on developing next-generation immuno-modulators to treat diseases such as cancer, today announced a strategic partnership with the Patrick G Johnston Centre for Cancer Research at Queen's...
March 20, 2023
Aviceda Therapeutics has completed a key regulatory milestone for its HALOS™ (High-Affinity Ligands of Sigelcs) technology platform and its lead ophthalmic drug candidate, AVD-104, a novel intravitreal glyco-conjugated nanoparticle.This represents a major step towards initiation of Phase 2 human clinical studies for...